Dennis Slamon

Awards as PI
Award Value
Disease Team Therapy Development III A Phase I dose escalation and expansion clinical trial in patients with advanced solid tumors $6,924,317
Disease Team Research I THERAPEUTIC OPPORTUNITIES TO TARGET TUMOR INITIATING CELLS IN SOLID TUMORS $19,979,660
Disease Team Research I Using Nell-1 to harness the osteogenic potential of adult stem cells $19,979,660
Total:
$46,883,637.00